Featuring the World’s First Wired-Speed Wireless Charging with CryoBoost®, innovative iPad keyboard cases, and a sneak peek at next-generation iPhone protection. BERLIN, Sept. 5, 2025 /PRNewswire/ — ESR, a global tech brand trusted by over 123 million users, unveiled its latest lineup of next-generation mobile products at IFA Berlin. Featuring the world’s first wired-speed wireless… Continue reading ESR Introduced Industry-First Tech for Charging, Protection, and Productivity at IFA 2025
Author: PR Newswire Online News
Official Title Revealed for Evangelion Game Project: “Evangelion: Δ Cross Reflections”
The world of ‘Evangelion’ is reimagined, where anime and gaming converge at the frontier of immersive experience.” SEOUL, South Korea, Sept. 5, 2025 /PRNewswire/ — Pixelity Inc. has officially revealed the title of the “Neon Genesis Evangelion” game project: “EVANGELION: Δ CROSS REFLECTIONS.” Alongside the announcement, the studio also unveiled the game’s official logo. Continue… Continue reading Official Title Revealed for Evangelion Game Project: “Evangelion: Δ Cross Reflections”
Envision Energy Signs Exclusivity Agreement with Mensis Enerji to Initially Drive 4.5 GW Wind Project in Turkey
IZMIR, Turkey, Sept. 5, 2025 /PRNewswire/ — Envision Energy, a global leader in green technology, announced a strategic partnership with Turkish energy company Mensis Enerji during the Turkish Wind Energy Congress (TWEC). This collaboration focuses on long-term systemic synergy across market development, technology cooperation, and policy advocacy, aiming to build a sustainable green energy ecosystem in… Continue reading Envision Energy Signs Exclusivity Agreement with Mensis Enerji to Initially Drive 4.5 GW Wind Project in Turkey
Aker Horizons ASA: Ex. dividend in-kind today
FORNEBU, Norway, Sept. 5, 2025 /PRNewswire/ — Issuer name: Aker Horizons ASA (the “Company”) Ex. Date: 5 September 2025 Type of corporate action: Distribution of shares in Aker Horizons Holding AS (“AKHH”) as dividend-in-kind Other information: The Company’s shares will be traded ex dividend of 1 (one) share in AKHH per share held in the Company from today,… Continue reading Aker Horizons ASA: Ex. dividend in-kind today
Aker Horizons ASA: Ex. dividend in-kind today
FORNEBU, Norway, Sept. 5, 2025 /PRNewswire/ — Issuer name: Aker Horizons ASA (the “Company”) Ex. Date: 5 September 2025 Type of corporate action: Distribution of shares in Aker Horizons Holding AS (“AKHH”) as dividend-in-kind Other information: The Company’s shares will be traded ex dividend of 1 (one) share in AKHH per share held in the Company from today,… Continue reading Aker Horizons ASA: Ex. dividend in-kind today
BlueNord: Preliminary Production for August 2025 and Revised Tyra Guidance
OSLO, Norway, Sept. 5, 2025 /PRNewswire/ — BlueNord ASA (“BlueNord” or the “Company”) has today announced its preliminary production figures for August 2025 and a revised production guidance for Tyra. In August 2025, the preliminary production was 37.2 mboepd net to BlueNord. The base assets, Dan, Gorm, and Halfdan, produced 21.9 mboepd net to the Company,… Continue reading BlueNord: Preliminary Production for August 2025 and Revised Tyra Guidance
Venturi Partners voltooit eerste afsluiting van Fonds II waarbij het $ 150 miljoen ophaalt en haar investeringsstrategie in snelgroeiende consumentenmerken in India en Zuidoost-Azië versterkt
Het fonds streeft naar een definitieve afsluiting van $ 225 miljoen in juni 2026 SINGAPORE, 5 september 2025 /PRNewswire/ — Venturi Partners, een toonaangevend groeifonds voor de consument kondigt aan dat het zijn eerste afsluiting van zijn tweede fonds heeft voltooid met 150 miljoen US dollar aan toegezegd kapitaal. Deze mijlpaal, gesteund door bestaande en… Continue reading Venturi Partners voltooit eerste afsluiting van Fonds II waarbij het $ 150 miljoen ophaalt en haar investeringsstrategie in snelgroeiende consumentenmerken in India en Zuidoost-Azië versterkt
Roche receives CE IVDR approval for HER2 (4B5) companion diagnostic test to identify HER2-ultralow breast cancer and biliary tract cancer patients
The VENTANA HER2 (4B5) test is now CE-IVDR approved to aid in the assessment of HER2-ultralow status to identify metastatic breast cancer patients who may be eligible for treatment with ENHERTU. The VENTANA HER2 (4B5) test is also now approved to help identify patients with previously-treated, unresectable or metastatic HER2-positive biliary tract cancer (BTC) who… Continue reading Roche receives CE IVDR approval for HER2 (4B5) companion diagnostic test to identify HER2-ultralow breast cancer and biliary tract cancer patients
Roche receives CE IVDR approval for HER2 (4B5) companion diagnostic test to identify HER2-ultralow breast cancer and biliary tract cancer patients
The VENTANA HER2 (4B5) test is now CE-IVDR approved to aid in the assessment of HER2-ultralow status to identify metastatic breast cancer patients who may be eligible for treatment with ENHERTU. The VENTANA HER2 (4B5) test is also now approved to help identify patients with previously-treated, unresectable or metastatic HER2-positive biliary tract cancer (BTC) who… Continue reading Roche receives CE IVDR approval for HER2 (4B5) companion diagnostic test to identify HER2-ultralow breast cancer and biliary tract cancer patients
CTCI Breaks Contract Record with NT$154.7bn EPC Tender in Partnership with Mitsubishi Power to Upgrade Tung Hsiao Power Plant
MIAOLI, Sept. 5, 2025 /PRNewswire/ — Taiwan’s leading engineering, procurement, and construction (EPC) group CTCI announced today that it has won an NT$154.7bn EPC tender jointly with Japan’s Mitsubishi Power Ltd. to build five new combined cycle generating units next to the existing Tung Hsiao Power Plant for Taiwan Power Company (Taipower), the state utility… Continue reading CTCI Breaks Contract Record with NT$154.7bn EPC Tender in Partnership with Mitsubishi Power to Upgrade Tung Hsiao Power Plant